PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2020

Jun 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2020-06-09

Reporting Person: ZAVRL FRANK (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-09	COMMON STOCK	A	25748	$0.00	Acquired	50993	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
COMMON STOCK	359076	Indirect
COMMON STOCK	550000	Indirect

Footnotes

F1: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.